Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.
about
Diarrhoea in adults (acute)A week in the life of a travel clinic.Review article: travellers' diarrhoea.Diarrhoea in adults (acute).Antibiotic treatment for travellers' diarrhoea.In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regionsPreparing patients to travel abroad safely. Part 4: Reducing risk of accidents, diarrhea, and sexually transmitted diseases.Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection.Empirical antimicrobial therapy for traveler's diarrhea.Campylobacters: the most common bacterial enteropathogens in the Nordic countries.Drug prophylaxis for travelers' diarrhea.Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolatesNew World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunityEndemic infectious diseases of Afghanistan.A stochastic assessment of the public health risks of the use of macrolide antibiotics in food animals.Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey.Clinical importance and epidemiology of quinolone resistance.Prevention and self-treatment of traveler's diarrhea.Expert review of the evidence base for prevention of travelers' diarrhea.Expert review of the evidence base for self-therapy of travelers' diarrhea.Diagnosis and treatment of bacterial diarrhea.Quinolone-resistant Campylobacter infections: risk factors and clinical consequences.Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999Prevention and treatment of traveler's diarrhea. Focus on antimicrobial agents.The Effect of Mass Azithromycin Distribution on Childhood Mortality: Beliefs and Estimates of Efficacy.Current and future developments in travelers' diarrhea therapy.Diagnostic approach to acute diarrheal illness in a military population on training exercises in Thailand, a region of campylobacter hyperendemicity.Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis.Campylobacter antimicrobial drug resistance among humans, broiler chickens, and pigs, FranceThe role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea.Antimicrobial prevention and therapy for travelers' infection.Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report.Resistant pathogens as causes of traveller's diarrhea globally and impact(s) on treatment failure and recommendations.Travellers' diarrhoea-a survey of practice.The practice of travel medicine: guidelines by the Infectious Diseases Society of America.Update on Traveler's Diarrhea.Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea.Diarrhea in the returned traveler.Medications for the prevention and treatment of travellers' diarrhea.
P2860
Q24605037-081FB5FC-FE12-4881-AD83-F3DD6A7D4F8DQ27477861-991B17BA-9FF1-4ECD-BFBA-2273D1CEE0E4Q33778796-B0A95C7D-D45D-422A-8D7E-B631C9F863D7Q33947397-11161829-698A-4584-9BC5-CF52697F0AC1Q33978592-2D975D2D-6455-4574-9096-CBA76881965DQ33981185-EC0B3BB9-3D44-4278-A077-CFCFD3A1165CQ34012155-0853BDD7-A3FD-4540-8D5A-667CE3EDDB54Q34046439-E4BCF34D-8011-4E41-B7E2-7F7B00A0D255Q34069481-5FBE856E-1199-453E-8D2E-0CA8EA2CCF5FQ34087406-EDA6D23F-A6EA-44DB-8440-4F761DF20B20Q34110485-E1829C93-B524-4592-910F-AA66A21265A0Q34194136-8658F825-DB51-4DD1-91CA-7427C33A8D4EQ34301241-50CE4AFC-7699-451B-925F-46A8255706F1Q34645383-945ED353-A8A8-4064-8D19-F28F2FE40398Q34798556-E0C0FF57-3689-43A5-8A37-0A12D748D875Q34805912-33A49D3F-B5EE-48E3-B2F1-8ACA96D52064Q34838791-9F73A552-F701-4D03-94D7-8F51819980C3Q34974972-BAB94E05-3EDF-4F60-A6A1-C79E36CB6946Q34987670-6E04BCBB-643A-455E-A77C-54466537D9D7Q34987675-BD6D3651-9A77-4F7B-A005-D7FB62EBA1C7Q35178767-4B984E90-F5EF-4DEF-9302-753E7F17DA6FQ35880423-907190F0-1636-4BF5-9DD6-7EAE5EB9D171Q35880517-A715315A-44E3-4875-A87A-09EAF4C2E126Q36014922-B6FCF34C-781A-4167-A0DF-B3C4292C22EBQ36404962-0904C4AB-034B-42C1-BBB1-1B597C235BD2Q36436259-FEE2D51B-14D9-432E-86D0-A4129D2058ACQ36505498-E7C232A2-6A5C-4DF7-8451-2704CBC406A8Q36539943-D7C3419D-CB92-4E11-9416-79097861EE85Q37264572-29E57800-3A85-4467-9044-32ABB4F4D862Q37302650-82006C58-6B20-47DB-8B46-CE2814FF2669Q37412963-8423784F-A872-4DFB-A004-E53F1895A173Q38573032-CC459642-8DD9-4A9D-889F-F2B034BA9A0FQ38682282-A4611E8D-5B92-4B2E-B3F9-4F11065C7E82Q38776966-B7547B4F-0251-4AB3-A9B7-7A989FF76E69Q38844218-B3E98551-D103-4648-A17A-6DBB3EE3B5E3Q39067681-87FC6F0A-FC70-4A8E-BF0A-09C677199E61Q39410276-1B51E560-B042-4C83-A7EF-54963B45D8C1Q39413710-A820F9ED-4A7A-44F9-853B-12985ACDA548Q39427985-A085F25D-A404-4FB2-9C5D-537D1370393DQ39513868-5C6C3C71-EB44-4743-B396-69119B70E6D8
P2860
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Use of azithromycin for the tr ...... xacin resistance is prevalent.
@en
Use of azithromycin for the tr ...... xacin resistance is prevalent.
@nl
type
label
Use of azithromycin for the tr ...... xacin resistance is prevalent.
@en
Use of azithromycin for the tr ...... xacin resistance is prevalent.
@nl
prefLabel
Use of azithromycin for the tr ...... xacin resistance is prevalent.
@en
Use of azithromycin for the tr ...... xacin resistance is prevalent.
@nl
P2093
P921
P356
P1476
Use of azithromycin for the tr ...... xacin resistance is prevalent.
@en
P2093
Echeverria P
Kuschner RA
Olafson RP
Pitarangsi C
P304
P356
10.1093/CLINIDS/21.3.536
P407
P577
1995-09-01T00:00:00Z